Congenital Adrenal Hyperplasia caused by compound heterozygosity of two novel CYP11B1gene variants.
Irene Fylaktou(Children's Hospital Agia Sophia), Christina Kanaka‐Gantenbein(National and Kapodistrian University of Athens), Amalia Sertedaki(National and Kapodistrian University of Athens), Penelope Smyrnaki
59th ESPE Annual Meeting (ESPE 2021 Online)
January 1, 2021
Cited by 0
Related Papers
Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome
|Journal of Allergy and Clinical Immunology|2010|78
Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA
|Journal of the Neurological Sciences|2018|44
Adapting the ACMG/AMP variant classification framework: A perspective from the ClinGen Hemoglobinopathy Variant Curation Expert Panel
|Human Mutation|2021|40
Nucleotide Variations in the <i>NPHS2</i> Gene in Greek Children with Steroid-Resistant Nephrotic Syndrome
|Genetic Testing and Molecular Biomarkers|2009|19
Molecular Analysis of the <i>CYP11B2</i> Gene in 62 Patients with Hypoaldosteronism Due to Aldosterone Synthase Deficiency
|The Journal of Clinical Endocrinology & Metabolism|2020|16